Bergonie Institute Breast Cancer Database
- Conditions
- Breast Cancer
- Registration Number
- NCT02893761
- Lead Sponsor
- Institut Bergonié
- Brief Summary
A database of breast cancer patients was established at Institute Bergonié since the 90s , to assess patients' survival, assess practice, search for prognostic factors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 21439
Inclusion Criteria
- Breast cancer
- Aged 18 years and over
- First treatment at Bergonie Institute
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall Survival 10 years
- Secondary Outcome Measures
Name Time Method Distant disease-free survival 10 years D-DFS, distant disease-free survival, as defined following DATECAN guidelines (Gourgou et al. Annals Oncol 2015). D-DFS is defined as the time to death or appearance/occurrence of metastases/distant recurrence, whichever occurs first
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular prognostic factors were identified in the Bergonie Institute's breast cancer database for patient stratification?
How does the Bergonie Institute's observational database compare to other breast cancer registries in terms of survival analysis methodologies?
What biomarkers correlate with treatment response in breast cancer subtypes tracked within the Bergonie Institute database?
Are there any novel therapeutic targets or drug combinations suggested by long-term data from the Bergonie Institute's breast cancer cohort?
What adverse event management strategies emerged from the Bergonie Institute's long-term breast cancer patient monitoring data?